210 related articles for article (PubMed ID: 6339024)
61. Adjuvant chemoimmunotherapy for gastric carcinoma.
Makowka L; Falk RE; Ambus U; Bugala R; Landi S
Can J Surg; 1980 Sep; 23(5):429-31. PubMed ID: 6159957
[TBL] [Abstract][Full Text] [Related]
62. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
Koh HK; Sober AJ; Harmon DC; Lew RA; Carey RW
Med Pediatr Oncol; 1985; 13(5):244-60. PubMed ID: 3897817
[TBL] [Abstract][Full Text] [Related]
63. [Immuno- and chemoimmunotherapy and prevention of metastasis in skin melanoma].
Trapeznikov NN; Iavorskiĭ VV; Vagner RI; Gorodilova VV; Knysh IT
Vestn Akad Med Nauk SSSR; 1978; (5):19-26. PubMed ID: 676458
[No Abstract] [Full Text] [Related]
64. Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.
Serrou B; Pujol H; Domas J; Gauci L
Recent Results Cancer Res; 1978; 68():363-6. PubMed ID: 752871
[No Abstract] [Full Text] [Related]
65. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.
Quirt IC; Shelley WE; Pater JL; Bodurtha AJ; McCulloch PB; McPherson TA; Paterson AH; Prentice R; Silver HK; Willan AR
J Clin Oncol; 1991 May; 9(5):729-35. PubMed ID: 2016615
[TBL] [Abstract][Full Text] [Related]
66. [Treatment of advanced or recurrent malignant melanoma].
Pettavel J; Banzet P
Schweiz Med Wochenschr; 1970 Jun; 100(23):988-92. PubMed ID: 5524714
[No Abstract] [Full Text] [Related]
67. Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapy.
Castel T; Estapé J; Viñolas N; Mascaró JM; Castro J; Vilalta A; Gratacós R; Daniels M; Palou J; Grau JJ
Dermatologica; 1991; 183(1):25-30. PubMed ID: 1769411
[TBL] [Abstract][Full Text] [Related]
68. [Immunotherapy of malignant melanoma].
Adler A
Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
[No Abstract] [Full Text] [Related]
69. [Experiences with immune BCG therapy of malignant melanoma].
Altmeyer P; Nödl F
Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562
[No Abstract] [Full Text] [Related]
70. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)].
Rundenstam CM
Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339
[No Abstract] [Full Text] [Related]
71. Rationale for complete metastasectomy in patients with stage IV metastatic melanoma.
Ollila DW; Gleisner AL; Hsueh EC
J Surg Oncol; 2011 Sep; 104(4):420-4. PubMed ID: 21858837
[TBL] [Abstract][Full Text] [Related]
72. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
Byrne MJ; Van Hazel G; Reynolds PM; Lemish WM; Holman CD
J Surg Oncol; 1983 Jun; 23(2):114-6. PubMed ID: 6343725
[TBL] [Abstract][Full Text] [Related]
73. Stage IV melanoma: completely resectable patients are scarce.
Wevers KP; Hoekstra HJ
Ann Surg Oncol; 2013 Jul; 20(7):2352-6. PubMed ID: 23392854
[TBL] [Abstract][Full Text] [Related]
74. Malignant melanoma (stage IIIB): a pilot study of adjuvant chemo-immunotherapy.
Paterson AH; McPherson TA; Willans DJ
Cancer Treat Rep; 1978 Apr; 62(4):571-3. PubMed ID: 350395
[No Abstract] [Full Text] [Related]
75. [Adjuvant chemotherapy in malignant melanoma after pretherapeutic sensitivity testing].
Zaumseil RP; Wohlrab W; Fiedler H; Wozniak KD
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):721-4. PubMed ID: 6172340
[No Abstract] [Full Text] [Related]
76. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.
Livingston PO; Wong GY; Adluri S; Tao Y; Padavan M; Parente R; Hanlon C; Calves MJ; Helling F; Ritter G
J Clin Oncol; 1994 May; 12(5):1036-44. PubMed ID: 8164027
[TBL] [Abstract][Full Text] [Related]
77. Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial.
Fisher RI; Terry WD; Hodes RJ; Rosenberg SA; Makuch R; Gordon HG; Fisher SG
Surg Clin North Am; 1981 Dec; 61(6):1267-77. PubMed ID: 7031934
[No Abstract] [Full Text] [Related]
78. Combined modality therapy of malignant melanoma.
Hersh EM; Gutterman JU; McBride CM
World J Surg; 1979 Jul; 3(3):329-43. PubMed ID: 382647
[No Abstract] [Full Text] [Related]
79. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
80. Surgical adjuvant therapy for malignant melanoma.
Pinsky CM; Oettgen HF
Surg Clin North Am; 1981 Dec; 61(6):1259-66. PubMed ID: 7031933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
